p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cellsRobert J. Ihry, Ajamete Kaykas, Kathleen A. Worringer et al.|Nature Medicine|2018Cited by 1k
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discoveryChaoyang Ye, Ajamete Kaykas|Nature Communications|2018Cited by 234
Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific GenesRobert J. Ihry, Ajamete Kaykas, Max R. Salick et al.|Cell Reports|2019Cited by 81
The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Cancer Discovery|2024Cited by 43
P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cellsRobert J. Ihry, Ajamete Kaykas, Kathleen A. Worringer et al.|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 7